Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

31,147 trials

2025-521209-42-00
Recruiting
A biomarker enrichment trial of anti-EGFR agents in patients with advanced colorectal cancer (aCRC) with wild-type RAS and right primary tumour location (right-PTL) - ARIEL-ENGIC 04 EU trial
Phase 4 · Germany, Spain, Italy · 37 sites
Registry update: 14 Oct 2026
NCT07867080
Recruiting
A Phase 3 Trial for Intravitreal Injection of 4D-150 in Adults With Diabetic Macular Edema (DME).
Phase 3 · China, Japan, Puerto Rico, United States · 92 sites
Registry update: 5 Nov 2026
NCT07871110
Recruiting
Safety, Efficacy and Pharmacokinetics of TT00420 Tablets Combined With Novel Endocrine Therapy in Patients With Metastatic Castration-resistant Prostate Cancer (mCRPC)
Phase 2 · China · 16 sites
Registry update: 13 Oct 2026
NCT07830719
Recruiting
Dose-finding Study of YMI024 to Assess Efficacy, Safety, and Tolerability in Adults With Stable Coronary Artery Disease and Elevated hsCRP
Phase 2 · Australia, Germany, United Kingdom, Japan, United States · 32 sites
Registry update: 15 Oct 2026
NCT07751978
Recruiting
Adaptation and Evaluation of an Intersectional Stigma Reduction Intervention to Increase HIV Care Engagement Among Women Who Use Drugs
Not applicable · Ukraine · 1 site
Registry update: 8 Oct 2026
NCT07632014
Recruiting
CAYA Cancer Prospective Cohort Study
Not applicable · Armenia, Egypt, Guatemala, Honduras, El Salvador · 6 sites
Registry update: 29 Sept 2026
NCT07613099
Recruiting
Fibrotic Disease Activity in Cardiopulmonary Disorders Using 18F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) PET/CT Imaging
Phase 3 · United States · 1 site
Registry update: 26 Oct 2026
NCT07287436
Recruiting
Elite AF IDE Trial (Elite AF)
Not applicable · United States · 2 sites
Registry update: 16 Oct 2026
2026-525489-23-00
Recruiting
Phase 3 Trial of Tarlatamab (SC vs IV) In Extensive-Stage Small Cell Lung Cancer After Platinum based First-line Chemotherapy (DeLLphi-315)
Phase 3 · Belgium, Germany, Spain, France, Greece, Hungary, Italy, Netherlands, Poland, Portugal, Romania · 62 sites
Registry update: 14 Sept 2026
NCT07809867
Recruiting
Pharmacokinetics of Elexacaftor/Tezacaftor/Ivacaftor in Cystic Fibrosis
Phase 4 · Italy · 4 sites
Registry update: 14 Oct 2026
NCT07810777
Recruiting
PRA-216 Atopic Dermatitis Safety and Efficacy Study
Phase 2 · Australia, New Zealand · 9 sites
Registry update: 28 Oct 2026
NCT07592767
Recruiting
RESvEraTrol in Parkinson's Disease (RESET)
Phase 2 · United States · 1 site
Registry update: 18 Sept 2026
NCT07670312
Recruiting
Evaluation of XYA02 in Patients With Advanced Solid Tumors
Phase 1/2 · Australia · 5 sites
Registry update: 25 Sept 2026
NCT07531199
Recruiting
Efficacy and Safety of a Releasable Intraluminal Suture Technique to Reduce Hypotony Following Glaucoma Surgery Using the Preserflo Device
Not applicable · France · 1 site
Registry update: 2 Oct 2026
NCT07864051
Recruiting
Predicting Plaque Growth Using Blood Flow Stress Markers: A Proof-of-Concept Study
Not applicable · United Kingdom · 1 site
Registry update: 7 Oct 2026
2026-526282-25-00
Recruiting
A Phase 1b Basket Study Evaluating B Cell Depletion in Blood and Tissue by Etentamig or ABBV-519 in Subjects with Moderate to Severe Systemic Lupus Erythematosus (SLE), Rheumatoid Arthritis (RA), or Sjögren's Disease (SjD)
Phase 1 · Germany · 1 site
Registry update: 10 Sept 2026
NCT07856927
Recruiting
To Share or Not To Share: Navigating Disclosure and Stigma Among Family Caregivers of Autistic Young Adults_Group Intervention
Not applicable · United States · 1 site
Registry update: 5 Oct 2026
NCT07555977
Recruiting
SUPERSTAR: Aspiration vs. Stent Retriever in Anterior Circulation LVO
Not applicable · China · 1 site
Registry update: 7 Oct 2026
NCT07604922
Recruiting
Investigating Vascular Properties of HEMI and SPG Signals in Individuals With or at Risk for Chronic Kidney Disease
Not applicable · France · 1 site
Registry update: 6 Nov 2026
NCT07795346
Recruiting
A Study of ATG-022 Compared With Investigator's Choice of Treatment in Claudin 18.2-Positive Advanced Gastric or Gastroesophageal Junction Adenocarcinoma
Phase 3 · China · 128 sites
Registry update: 29 Oct 2026

Ordered by registry start date. Freshness and sponsorship never change the order.